Literature DB >> 19669305

Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease.

Payal Bhardwaj1, Kaushal Madan, Sandeep Thareja, Yogendra Kumar Joshi, Anoop Saraya.   

Abstract

PURPOSE: Altered redox status has been implicated in pathogenesis of alcoholic liver disease (ALD) as well as in nonalcoholic fatty liver disease (NAFLD). This study was planned to find the relative role of redox status in these two diseases.
METHODS: A total of 44 patients with ALD and 32 patients with NAFLD and 25 apparently healthy controls were included in the study. Redox status was estimated by measuring oxidative stress (superoxide dismutase (SOD) and lipid peroxidation products as thiobarbituric acid reactive substances (TBARS)) and antioxidant status (ferric reducing ability of plasma (FRAP) and vitamin C).
RESULTS: TBARS level was raised significantly in both ALD (3.5 (2.3-9.4) vs. 1.8 (0.5-4.1) nmol/ml; P = 0.0001) and NAFLD (5.1 (1-10.2) vs. 1.82 (0.51-4.1) nmol/ml; P = 0.0001) as compared with controls, but was not different between ALD and NAFLD. SOD was significantly higher in ALD as compared to NAFLD (2.4 (1.3-7.8) vs. 0.68 (0.05-19.1) U/ml; P = 0.0001) and controls (1.12 (0.01-3.5) U/ml; P = 0.001). FRAP was lower in ALD as compared with NAFLD (345.4 (56-615.9) vs. 434.1 (197.6-733.3) mumol of Fe(+2) liberated; P = 0.001) but similar to that of controls (340.9 (141.5-697.5) mumol of Fe(+2) liberated).
CONCLUSIONS: ALD patients have a higher degree of redox imbalance as compared with NAFLD patients.

Entities:  

Year:  2008        PMID: 19669305      PMCID: PMC2716853          DOI: 10.1007/s12072-008-9060-7

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  43 in total

Review 1.  Oxidants and human disease: some new concepts.

Authors:  B Halliwell
Journal:  FASEB J       Date:  1987-11       Impact factor: 5.191

2.  Oxygen free radicals and congestive heart failure.

Authors:  J J Belch; A B Bridges; N Scott; M Chopra
Journal:  Br Heart J       Date:  1991-05

Review 3.  Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress.

Authors:  G Robertson; I Leclercq; G C Farrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-11       Impact factor: 4.052

Review 4.  Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans.

Authors:  H K Vincent; A G Taylor
Journal:  Int J Obes (Lond)       Date:  2006-03       Impact factor: 5.095

Review 5.  Oxidative stress and signal transduction pathways in alcoholic liver disease.

Authors:  Tomás Zima; Marta Kalousová
Journal:  Alcohol Clin Exp Res       Date:  2005-11       Impact factor: 3.455

6.  Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).

Authors:  Kaushal Madan; Payal Bhardwaj; Sandeep Thareja; Siddhartha D Gupta; Anoop Saraya
Journal:  J Clin Gastroenterol       Date:  2006 Nov-Dec       Impact factor: 3.062

7.  Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein.

Authors:  P M Abuja
Journal:  FEBS Lett       Date:  1999-03-12       Impact factor: 4.124

Review 8.  Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis.

Authors:  Shivakumar Chitturi; Jacob George
Journal:  Curr Gastroenterol Rep       Date:  2003-02

9.  Recent trends of hyperuricemia and obesity in Japanese male adolescents, 1991 through 2002.

Authors:  Toshio Ogura; Kazuharu Matsuura; Yosuke Matsumoto; Yukari Mimura; Masayuki Kishida; Fumio Otsuka; Kazuo Tobe
Journal:  Metabolism       Date:  2004-04       Impact factor: 8.694

10.  Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis.

Authors:  Mehmet Koruk; Seyithan Taysi; M Cemil Savas; Omer Yilmaz; Fatih Akcay; Metin Karakok
Journal:  Ann Clin Lab Sci       Date:  2004       Impact factor: 1.256

View more
  4 in total

Review 1.  Biliverdin reductase and bilirubin in hepatic disease.

Authors:  Lauren Weaver; Abdul-Rizaq Hamoud; David E Stec; Terry D Hinds
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-01       Impact factor: 4.052

Review 2.  Nonalcoholic fatty liver disease in India - a lot done, yet more required!

Authors:  Ajay Duseja
Journal:  Indian J Gastroenterol       Date:  2010-12-30

3.  Glutaredoxin-1 Deficiency Causes Fatty Liver and Dyslipidemia by Inhibiting Sirtuin-1.

Authors:  Di Shao; Jingyan Han; Xiuyun Hou; Jessica Fry; Jessica B Behring; Francesca Seta; Michelle T Long; Hemant K Roy; Richard A Cohen; Reiko Matsui; Markus M Bachschmid
Journal:  Antioxid Redox Signal       Date:  2017-02-16       Impact factor: 8.401

4.  Development and validation of a prognostic model related to pyroptosis-related genes for esophageal squamous cell carcinoma using bioinformatics analysis.

Authors:  Weiguang Zhang; Peipei Zhang; Junfei Jiang; Kaiming Peng; Zhimin Shen; Mingqiang Kang
Journal:  J Thorac Dis       Date:  2022-08       Impact factor: 3.005

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.